Nanoparticles serve as ideal vehicles to deliver siRNA molecules to NSCLC and suppress the oncogene of interest to sensitize to therapeutics.

Schematic diagram of polymeric reduction‐responsive drug‐loaded nanoparticles delivering its cargo to tumor cells presenting high levels of glutathione following intravenous administration.

Various experimental approaches in VL nanodiagnostics: (a) detection of amplified DNA using primers labeled with nanoparticles; (b) Rapid visual detection platform employing nanoparticles in the presence of extracted total RNA from infected macrophages; (c) label‐free immuno‐sensor by immobilizing a peptide‐based probe onto nano platform.

Two‐dimensional (2D) metal organic frameworks (MOFs) are emerging class of biomaterials with high porosity, biocompatibility, and ability to introduce desired functionality within the structural framework. This review highlights biomedical applications of 2D MOFs for therapeutic delivery, tissue engineering, bioimaging, and biosensing.

Cellular mechanisms exploited in cancer nanomedicine.

Overview of biofabrication strategies to create engineered tissues and organs

Surface‐enhanced Raman scatting nanoparticles can be exploited in various biomedical imaging application.

One example of radiolabeled metal‐based nanoparticles (MNPs) along with their noninvasive imaging evaluation is shown here to represent the potential use of MNPs as nanotheranostics of cancer. Hollow gold nanoparticles were radiolabeled with 103Pd through an electroless deposited copper layer followed by 103Pd galvanic replacement of copper. The in vivo distribution evaluation of the radiolabeled nanoparticles was performed by single‐photon emission computed tomography imaging fused with computed tomography in a prostate cancer xenograft mouse model of PC3‐tumor over 7 weeks (Moeendarbari et al., 2016).

Current advances, limitations and future prospects for nanomaterial applications in oral and craniofacial tissue regeneration and disease treatment.

Recent advances in development of dendritic polymer‐based nanomedicines for cancer diagnosis.

The development of new type of cell penetrating peptides and their functionalization of polymeric nanoplatforms facilitates their drug delivery for enhanced therapeutic efficacy.